Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles G Drake

Showing results (121-130 of 266) with videos related to

Pageof 27
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cellsJoseph F Grosso, Monica V Goldberg, Derese Getnet, et al.
American Journal of Clinical and Experimental Urology|March 27, 2020
Transcriptional profiling of tumor associated macrophages in human renal cell carcinoma reveals significant heterogeneity and opportunity for immunomodulationThomas R Nirschl, Margueritta El Asmar, Wesley W Ludwig, et al.
Transfusion|March 8, 2014
Allogeneic versus autologous blood transfusion and survival after radical prostatectomyHeather J Chalfin, Steven M Frank, Zhaoyong Feng, et al.
Journal of Neuro-Oncology|June 14, 2015
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomasJian L Campian, Xiaobu Ye, Douglas E Gladstone, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2016
Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumorsLudmila Danilova, Hao Wang, Joel Sunshine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2025
Human kallikrein 2: A novel lineage-specific surface target in prostate cancerFei Shen, Ryan Smith, Theresa McDevitt, et al.
Journal for Immunotherapy of Cancer|May 10, 2020
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory responseFernanda I Arnaldez, Steven J O'Day, Charles G Drake, et al.
The Prostate|March 23, 2019
Consequences of interleukin 1β-triggered chronic inflammation in the mouse prostate gland: Altered architecture associated with prolonged CD4<sup>+</sup> infiltration mimics human proliferative inflammatory atrophyArya Ashok, Rebecca Keener, Michael Rubenstein, et al.
Oncotarget|July 19, 2016
Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancerJulie N Graff, Joshi J Alumkal, Charles G Drake, et al.
Gastroenterology|November 1, 2020
PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in MiceWoosook Kim, Timothy H Chu, Henrik Nienhüser, et al.
Pageof 27

Showing results (121-130 of 266) with videos related to

Sort By:
Pageof 27
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cellsJoseph F Grosso, Monica V Goldberg, Derese Getnet, et al.
American Journal of Clinical and Experimental Urology|March 27, 2020
Transcriptional profiling of tumor associated macrophages in human renal cell carcinoma reveals significant heterogeneity and opportunity for immunomodulationThomas R Nirschl, Margueritta El Asmar, Wesley W Ludwig, et al.
Transfusion|March 8, 2014
Allogeneic versus autologous blood transfusion and survival after radical prostatectomyHeather J Chalfin, Steven M Frank, Zhaoyong Feng, et al.
Journal of Neuro-Oncology|June 14, 2015
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomasJian L Campian, Xiaobu Ye, Douglas E Gladstone, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2016
Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumorsLudmila Danilova, Hao Wang, Joel Sunshine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2025
Human kallikrein 2: A novel lineage-specific surface target in prostate cancerFei Shen, Ryan Smith, Theresa McDevitt, et al.
Journal for Immunotherapy of Cancer|May 10, 2020
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory responseFernanda I Arnaldez, Steven J O'Day, Charles G Drake, et al.
The Prostate|March 23, 2019
Consequences of interleukin 1β-triggered chronic inflammation in the mouse prostate gland: Altered architecture associated with prolonged CD4<sup>+</sup> infiltration mimics human proliferative inflammatory atrophyArya Ashok, Rebecca Keener, Michael Rubenstein, et al.
Oncotarget|July 19, 2016
Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancerJulie N Graff, Joshi J Alumkal, Charles G Drake, et al.
Gastroenterology|November 1, 2020
PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in MiceWoosook Kim, Timothy H Chu, Henrik Nienhüser, et al.
Pageof 27